Progenics Pharma (PGNX)

5.24 -0.11 (2.06%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/2/18 *Est.)

Latest Headlines

Form SC 13D/A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. September 19, 2019 5:23 PM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL September 19, 2019 6:02 AM - SEC Filing Progenics Confirms Notice of Preliminary Consent Solicitation by Velan Capital, L.P. Despite Repeated Efforts by the Company to Reach a Reasonable Resolution September 18, 2019 5:00 PM - StreetInsider Progenics Confirms Notice of Preliminary Consent Solicitation by Velan Capital, L.P. Despite Repeated Efforts by the Company to Reach a Reasonable Resolution September 18, 2019 4:59 PM - Globe NewsWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. September 18, 2019 3:31 PM - SEC Filing Velan Launches Consent Solicitation to Reconstitute the Progenics Board With Its Five Highly-Qualified, Independent Director Nominees September 18, 2019 8:55 AM - BizWire Form PREC14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. September 18, 2019 8:35 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Sep 09 Filed by: Altiva Management Inc. September 11, 2019 1:33 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Sep 05 Filed by: LTE Management, LLC September 9, 2019 6:14 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Sep 03 Filed by: Altiva Management Inc. September 5, 2019 4:38 PM - SEC Filing Progenics Pharmaceuticals Announces Presentation at the International Conference on Immunotherapy Radiotherapy Combinations September 3, 2019 8:31 AM - StreetInsider Progenics Pharmaceuticals Announces Presentation at the International Conference on Immunotherapy Radiotherapy Combinations September 3, 2019 8:30 AM - Globe NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Aug 27 August 28, 2019 6:01 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Aug 23 Filed by: Altiva Management Inc. August 27, 2019 3:46 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Altiva Management Inc. August 27, 2019 3:42 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Nohria Virinder August 27, 2019 3:40 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: LTE Management, LLC August 27, 2019 3:37 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Sarpangal Deepak August 27, 2019 3:29 PM - SEC Filing Form 3 PROGENICS PHARMACEUTICAL For: Aug 22 Filed by: Cooke Terence August 27, 2019 3:25 PM - SEC Filing Form SC 13D/A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. August 26, 2019 5:03 PM - SEC Filing BTIG Reiterates Buy Rating on Progenics Pharmaceuticals (PGNX) August 12, 2019 9:29 AM - StreetInsider Velan Highlights Progenics Pharmaceuticals' Continued Mismanagement Following Q2 2019 Earnings Results August 12, 2019 8:00 AM - PR NewsWire Form 10-Q PROGENICS PHARMACEUTICAL For: Jun 30 August 9, 2019 4:05 PM - SEC Filing Form 8-K PROGENICS PHARMACEUTICAL For: Aug 09 August 9, 2019 8:01 AM - SEC Filing Progenics Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update August 9, 2019 7:30 AM - Globe NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Aug 07 August 8, 2019 4:04 PM - SEC Filing Progenics Pharmaceuticals Announces Additional Governance Enhancements August 8, 2019 8:01 AM - Globe NewsWire Progenics Pharmaceuticals Announces Additional Governance Enhancements August 8, 2019 8:01 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Aug 06 August 6, 2019 4:02 PM - SEC Filing Progenics Pharma (PGNX) Announces CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA August 6, 2019 8:39 AM - StreetInsider CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA® (iobenguane I 131) August 6, 2019 8:31 AM - Globe NewsWire CMS Grants New Technology Add-On Payment for Inpatient Use of AZEDRA® (iobenguane I 131) August 6, 2019 8:31 AM - StreetInsider Form 8-K PROGENICS PHARMACEUTICAL For: Aug 05 August 5, 2019 4:02 PM - SEC Filing Progenics Pharma (PGNX) Reports Complete Enrollment in Pivotal Phase 3 CONDOR Study of PyL for the Detection of Prostate Cancer August 5, 2019 8:37 AM - StreetInsider Progenics Pharmaceuticals Completes Enrollment in Pivotal Phase 3 CONDOR Study of PyL for the Detection of Prostate Cancer August 5, 2019 8:31 AM - StreetInsider Progenics Pharmaceuticals Completes Enrollment in Pivotal Phase 3 CONDOR Study of PyL for the Detection of Prostate Cancer August 5, 2019 8:30 AM - Globe NewsWire Progenics Pharmaceuticals Sets Second Quarter 2019 Financial Results and Business Update Call for August 9 August 1, 2019 8:31 AM - StreetInsider Progenics Pharmaceuticals Sets Second Quarter 2019 Financial Results and Business Update Call for August 9 August 1, 2019 8:30 AM - Globe NewsWire Brookline Capital Markets Starts Progenics Pharmaceuticals (PGNX) at Buy July 29, 2019 4:22 PM - StreetInsider Progenics Pharmaceuticals Announces Collaboration with Veterans Affairs on the AI Research Program for Medical Image Analysis July 25, 2019 8:31 AM - StreetInsider Progenics Pharmaceuticals Announces Collaboration with Veterans Affairs on the AI Research Program for Medical Image Analysis July 25, 2019 8:30 AM - Globe NewsWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. July 22, 2019 4:57 PM - SEC Filing Form 8-K/A PROGENICS PHARMACEUTICAL For: Jul 11 July 22, 2019 4:51 PM - SEC Filing Velan Announces Progenics Pharmaceuticals Stockholders Support its Campaign for Change at Progenics' 2019 Annual Meeting July 22, 2019 8:00 AM - PR NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Jul 17 July 18, 2019 4:02 PM - SEC Filing Court Upholds The Validity And Determined Actavis' Infringement Of Patent Protecting RELISTOR® Tablets July 17, 2019 7:41 PM - PR NewsWire Form 8-K PROGENICS PHARMACEUTICAL For: Jul 11 July 17, 2019 4:43 PM - SEC Filing Progenics Pharma (PGNX) Action Said Tied to Ruling July 17, 2019 3:10 PM - StreetInsider Form 4 PROGENICS PHARMACEUTICAL For: Jul 11 Filed by: WILLIAMS NICOLE July 15, 2019 9:03 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Jul 11 Filed by: SCHEINBERG DAVID A July 15, 2019 9:03 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Jul 11 Filed by: KISHBAUCH MICHAEL D July 15, 2019 9:02 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Jul 11 Filed by: Ferrante Karen Jean July 15, 2019 9:02 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Jul 11 Filed by: Crowley Peter J July 15, 2019 9:02 AM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Jul 11 Filed by: Campbell Bradley L July 15, 2019 9:01 AM - SEC Filing Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders July 12, 2019 9:12 AM - StreetInsider Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders July 12, 2019 9:11 AM - Globe NewsWire Form DEFA14A PROGENICS PHARMACEUTICAL July 8, 2019 2:31 PM - SEC Filing Form 4 PROGENICS PHARMACEUTICAL For: Jul 03 Filed by: Campbell Bradley L July 8, 2019 12:33 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. July 8, 2019 11:04 AM - SEC Filing Progenics Urges Shareholders to Vote Today “FOR” the Highly Qualified Director Candidates on the WHITE Proxy Card July 8, 2019 8:31 AM - Globe NewsWire Progenics Urges Shareholders to Vote Today “FOR” the Highly Qualified Director Candidates on the WHITE Proxy Card July 8, 2019 8:31 AM - StreetInsider Velan Reminds Stockholders to Follow ISS' Recommendation by Voting "Against" Progenics Pharmaceuticals Directors Peter Crowley and Michael Kishbauch July 8, 2019 8:00 AM - PR NewsWire Progenics Pharmaceuticals Strengthens Management Team with Appointment of Huw Jones as Vice President, Commercial July 8, 2019 7:31 AM - StreetInsider Progenics Pharmaceuticals Strengthens Management Team with Appointment of Huw Jones as Vice President, Commercial July 8, 2019 7:31 AM - Globe NewsWire Form 4 PROGENICS PHARMACEUTICAL For: Jul 01 Filed by: SCHEINBERG DAVID A July 3, 2019 8:56 AM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL July 1, 2019 10:20 AM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. July 1, 2019 8:58 AM - SEC Filing Velan Urges Stockholders To Follow ISS' Recommendation By Voting "Against" Progenics Pharmaceuticals Directors Peter Crowley And Michael Kishbauch July 1, 2019 8:00 AM - PR NewsWire Leading Independent Proxy Advisory Firm Glass Lewis Recommends Progenics Shareholders Vote “FOR” ALL of Progenics’ Director Nominees July 1, 2019 7:01 AM - Globe NewsWire Leading Independent Proxy Advisory Firm Glass Lewis Recommends Progenics Shareholders Vote “FOR” ALL of Progenics’ Director Nominees July 1, 2019 7:01 AM - StreetInsider Form DEFA14A PROGENICS PHARMACEUTICAL June 28, 2019 3:50 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. June 28, 2019 1:29 PM - SEC Filing ISS Supports Velan's Call for Change by Recommending Stockholders Vote "Against" Progenics Pharmaceuticals Directors Peter Crowley and Michael Kishbauch June 28, 2019 11:40 AM - PR NewsWire Form DEFA14A PROGENICS PHARMACEUTICAL June 28, 2019 10:52 AM - SEC Filing Progenics Reiterates Targeted Directors’ Indispensable Experience and Leadership Critical to the Company’s Long-Term Success June 28, 2019 10:32 AM - StreetInsider Progenics Reiterates Targeted Directors’ Indispensable Experience and Leadership Critical to the Company’s Long-Term Success June 28, 2019 10:31 AM - Globe NewsWire Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. June 28, 2019 8:59 AM - SEC Filing Form DEFA14A PROGENICS PHARMACEUTICAL June 28, 2019 6:06 AM - SEC Filing Velan Clarifies Interactions with Progenics Pharmaceuticals' Board of Directors June 28, 2019 12:01 AM - PR NewsWire Progenics Pharmaceuticals Details Recent Good Faith Efforts to Settle with Velan Capital June 27, 2019 9:01 PM - StreetInsider Progenics Pharmaceuticals Details Recent Good Faith Efforts to Settle with Velan Capital June 27, 2019 9:00 PM - Globe NewsWire Form 4 PROGENICS PHARMACEUTICAL For: Jun 26 Filed by: Crowley Peter J June 27, 2019 4:34 PM - SEC Filing Form DFAN14A PROGENICS PHARMACEUTICAL Filed by: Altiva Management Inc. June 25, 2019 11:03 AM - SEC Filing Progenics Pharma (PGNX) Says Data Presented at SNMMI Meeting Highlights Potential of its PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer June 25, 2019 8:36 AM - StreetInsider Data Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting Highlights Potential of Progenics’ PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer June 25, 2019 8:31 AM - StreetInsider Data Presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2019 Annual Meeting Highlights Potential of Progenics’ PSMA-Targeted Imaging Agent, PyL, in Detecting Prostate Cancer June 25, 2019 8:30 AM - Globe NewsWire Velan Releases Presentation Reiterating the Facts and Setting The Record Straight for Progenics Pharmaceuticals' Stockholders June 25, 2019 8:29 AM - PR NewsWire Form DEFA14A PROGENICS PHARMACEUTICAL June 24, 2019 4:45 PM - SEC Filing Form SC 13G PROGENICS PHARMACEUTICAL Filed by: FARALLON CAPITAL MANAGEMENT LLC June 24, 2019 4:40 PM - SEC Filing Independent Readers Using Progenics’ PSMA AI Demonstrated a Statistically Significant Improvement of Accuracy, Speed, and Reproducibility Over Readers Without PSMA AI June 24, 2019 8:31 AM - StreetInsider Independent Readers Using Progenics’ PSMA AI Demonstrated a Statistically Significant Improvement of Accuracy, Speed, and Reproducibility Over Readers Without PSMA AI June 24, 2019 8:30 AM - Globe NewsWire Progenics Pharma (PGNX) Files Presentation with SEC Challenging 'Flawed Arguments' by Velan Capital June 24, 2019 8:11 AM - StreetInsider Progenics Pharmaceuticals Files Supplemental Investor Presentation Rebutting Velan’s Latest Inaccurate Claims June 24, 2019 8:01 AM - Globe NewsWire Progenics Pharmaceuticals Files Supplemental Investor Presentation Rebutting Velan’s Latest Inaccurate Claims June 24, 2019 8:01 AM - StreetInsider Form DEFA14A PROGENICS PHARMACEUTICAL June 24, 2019 7:48 AM - SEC Filing Full Article List